• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas.促肾上腺皮质激素分泌型垂体腺瘤经蝶窦内镜手术后的并发症发生率:与生长激素分泌型及无功能腺瘤的对比分析
J Neurol Surg B Skull Base. 2021 Mar 2;83(Suppl 2):e274-e283. doi: 10.1055/s-0041-1725029. eCollection 2022 Jun.
2
Immediate and delayed postoperative morbidity in functional and non-functioning pituitary adenomas.功能性和非功能性垂体腺瘤的即刻和延迟术后并发症。
Pituitary. 2012 Sep;15(3):380-5. doi: 10.1007/s11102-011-0331-2.
3
Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center.经鼻内镜蝶窦入路垂体瘤切除术:垂体瘤治疗中心 228 例垂体瘤的手术结果。
Pituitary. 2010;13(1):68-77. doi: 10.1007/s11102-009-0195-x. Epub 2009 Aug 21.
4
Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.经鼻内镜下再次手术治疗生长激素型垂体腺瘤:文献系统回顾和荟萃分析的系列报告。
J Neurosurg. 2018 Aug;129(2):404-416. doi: 10.3171/2017.2.JNS162673. Epub 2017 Sep 1.
5
Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.经鼻内镜蝶窦入路手术治疗功能性垂体腺瘤。
Neurosurg Focus. 2011 Apr;30(4):E10. doi: 10.3171/2011.1.FOCUS10317.
6
Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.首次经蝶窦手术治疗生长激素、促肾上腺皮质激素和泌乳素分泌型垂体腺瘤后的内分泌学结果。
Acta Neurochir (Wien). 2002 Jun;144(6):555-61; discussion 561. doi: 10.1007/s00701-002-0938-1.
7
Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas.1166例垂体腺瘤的鼻内镜经蝶窦手术
Surg Endosc. 2015 Jun;29(6):1270-80. doi: 10.1007/s00464-014-3815-0. Epub 2014 Oct 1.
8
Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.生长激素型垂体腺瘤单纯经鼻蝶窦入路切除术的结果。
Neurosurg Focus. 2010 Oct;29(4):E5. doi: 10.3171/2010.7.FOCUS10153.
9
Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.影响经蝶窦显微手术治疗垂体腺瘤效果的因素:184 例患者研究。
Hormones (Athens). 2013 Apr-Jun;12(2):254-64. doi: 10.14310/horm.2002.1409.
10
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.内镜经蝶窦手术治疗肢端肥大症患者中肿瘤特征及术前术后激素水平对激素缓解的影响。
Neurosurg Focus. 2020 Jun;48(6):E10. doi: 10.3171/2020.3.FOCUS2080.

本文引用的文献

1
Complications Associated With Transsphenoidal Pituitary Surgery: Review of the Literature.经蝶窦垂体手术相关并发症:文献综述
Neurosurgery. 2018 Sep 1;65(CN_suppl_1):69-73. doi: 10.1093/neuros/nyy160.
2
A Survey on Pituitary Surgery in Italy.意大利垂体手术调查
World Neurosurg. 2019 Mar;123:e440-e449. doi: 10.1016/j.wneu.2018.11.186. Epub 2018 Nov 27.
3
Predictors of Postoperative Diabetes Insipidus Following Endoscopic Resection of Pituitary Adenomas.垂体腺瘤内镜切除术后尿崩症的预测因素
J Endocr Soc. 2018 Jul 27;2(9):1010-1019. doi: 10.1210/js.2018-00121. eCollection 2018 Sep 1.
4
Microsurgical therapy of pituitary adenomas.垂体腺瘤的显微外科治疗。
Endocrine. 2018 Jan;59(1):72-81. doi: 10.1007/s12020-017-1458-3. Epub 2017 Oct 24.
5
Preoperative risk factors for postoperative complications in endoscopic pituitary surgery: a systematic review.内镜垂体手术术后并发症的术前危险因素:系统评价。
Pituitary. 2018 Feb;21(1):84-97. doi: 10.1007/s11102-017-0839-1.
6
Risk Factors and Management of Intraoperative Cerebrospinal Fluid Leaks in Endoscopic Treatment of Pituitary Adenoma: Analysis of 492 Patients.垂体腺瘤内镜治疗中术中心脑脊液漏的危险因素及处理:492例患者分析
World Neurosurg. 2017 May;101:390-395. doi: 10.1016/j.wneu.2017.01.119. Epub 2017 Feb 10.
7
Predictors and Rates of Delayed Symptomatic Hyponatremia after Transsphenoidal Surgery: A Systematic Review [corrected].经蝶窦手术后延迟性症状性低钠血症的预测因素及发生率:一项系统评价[校正后]
World Neurosurg. 2016 Apr;88:1-6. doi: 10.1016/j.wneu.2016.01.022. Epub 2016 Jan 22.
8
Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.经蝶窦手术治疗无功能垂体腺瘤后内分泌功能的改善与恶化:发生率、时间进程及影像学分析
J Neurosurg. 2016 Mar;124(3):589-95. doi: 10.3171/2015.1.JNS141543. Epub 2015 Aug 7.
9
Postoperative Low-Flow Cerebrospinal Fluid Leak of Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenoma--Wait and See, or Lumbar Drain?垂体腺瘤经鼻内镜经蝶窦手术术后低流量脑脊液漏——观察等待,还是行腰大池引流?
J Craniofac Surg. 2015 Jun;26(4):1261-4. doi: 10.1097/SCS.0000000000001691.
10
Risk factors for postoperative cerebrospinal fluid leak and meningitis after expanded endoscopic endonasal surgery.扩大经鼻内镜手术后脑脊液漏和脑膜炎的危险因素
J Clin Neurosci. 2015 Jan;22(1):48-54. doi: 10.1016/j.jocn.2014.08.009. Epub 2014 Nov 22.

促肾上腺皮质激素分泌型垂体腺瘤经蝶窦内镜手术后的并发症发生率:与生长激素分泌型及无功能腺瘤的对比分析

Complication Rates after Endoscopic Transsphenoidal Surgery for ACTH-Secreting Pituitary Adenomas: A Comparative Analysis with GH and Nonfunctioning Adenomas.

作者信息

Aibar-Durán Juan Á, Oladotun-Anka Michael, Asencio-Cortés Carlos, Valassi Elena, Webb Susan, Gras-Cabrerizo Juan R, Monserrat-Gili Joan, Ribó Pere Tresserras, Muñoz-Hernández Fernando

机构信息

Department of Neurosurgery, Hospital de la Santa Creu i Sant Pau, Barcelona (Spain), Autonomous University of Barcelona (AUB), Barcelona, Spain.

Department of Endocrinology, Hospital de la Santa Creu i Sant Pau, Barcelona (Spain), Autonomous University of Barcelona (AUB), Barcelona, Spain.

出版信息

J Neurol Surg B Skull Base. 2021 Mar 2;83(Suppl 2):e274-e283. doi: 10.1055/s-0041-1725029. eCollection 2022 Jun.

DOI:10.1055/s-0041-1725029
PMID:35832977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9272304/
Abstract

Some complications have been more frequently reported after surgery for adrenocorticotropin hormone (ACTH)-secreting pituitary adenomas. We compared complication rates in patients with ACTH-secreting pituitary adenomas with those in patients with growth hormone secreting pituitary adenomas (growth hormone [GH] group) and nonfunctioning adenomas (nonfunctioning group).  A comparative three-group analysis was performed for all patients who had endoscopic transsphenoidal surgery for pituitary adenomas at our center between January 2011 and May 2019. Variables included demographics, preoperative clinical and radiological characteristics, and postoperative radiological and endocrinological outcomes. Complications were divided into four categories: endocrinological, neurosurgical, medical, and ENT (ear-nose-throat)-related complications. Univariate and multivariate statistical analysis were performed.  A total of 111 patients with pituitary adenomas and a mean age of 53.7 years were included (25 ACTH, 35 GH, and 51 nonfunctioning adenomas). Overall, 28 patients had microadenomas (25.2%) and 83 had macroadenomas (74.8%). Univariate statistical analysis for complications between groups showed no differences in neurosurgical and medical complications. Transient diabetes insipidus and postsurgical bacterial sinusitis were the only variables more frequently seen in the ACTH group (  = 0.01 and 0.04, respectively). Multivariate analysis for transient diabetes insipidus showed no differences between groups (  = 0.58).  Complication rates were similar in all three adenoma groups, particularly concerning major infections, thrombotic events, postoperative cerebrospinal fluid (CSF) leak, and transient diabetes insipidus. Transient diabetes insipidus was related with adenoma size and intraoperative CSF leak. Despite postoperative bacterial sinusitis was statistically higher in the ACTH group, this data should be interpreted with caution given the low number of patients with this complication.

摘要

促肾上腺皮质激素(ACTH)分泌型垂体腺瘤手术后,一些并发症的报告更为频繁。我们比较了ACTH分泌型垂体腺瘤患者与生长激素分泌型垂体腺瘤患者(生长激素[GH]组)和无功能腺瘤患者(无功能组)的并发症发生率。

对2011年1月至2019年5月期间在我们中心接受垂体腺瘤内镜经蝶窦手术的所有患者进行了三组比较分析。变量包括人口统计学、术前临床和放射学特征,以及术后放射学和内分泌学结果。并发症分为四类:内分泌、神经外科、内科和耳鼻喉(ENT)相关并发症。进行了单因素和多因素统计分析。

共纳入111例垂体腺瘤患者,平均年龄53.7岁(25例ACTH腺瘤、35例GH腺瘤和51例无功能腺瘤)。总体而言,28例患者为微腺瘤(25.2%),83例为大腺瘤(74.8%)。组间并发症的单因素统计分析显示,神经外科和内科并发症无差异。短暂性尿崩症和术后细菌性鼻窦炎是ACTH组中仅有的更常见变量(分别为P = 0.01和0.04)。短暂性尿崩症的多因素分析显示组间无差异(P = 0.58)。

所有三个腺瘤组的并发症发生率相似,尤其是在严重感染、血栓形成事件、术后脑脊液(CSF)漏和短暂性尿崩症方面。短暂性尿崩症与腺瘤大小和术中脑脊液漏有关。尽管ACTH组术后细菌性鼻窦炎在统计学上较高,但鉴于该并发症患者数量较少,该数据应谨慎解读。